Promescent Delay Wipes

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: Promescent Delay Wipes
Generic name: BENZOCAINE
Manufacturer: Absorption
Product type: HUMAN OTC DRUG
SPL set ID: f0a5b6be-acc5-473c-9054-b9534e769db1
SPL ID: 11d32fcd-926d-7021-e063-6394a90a0499
Version: 7
Effective date: 2024-02-20
Source export date: 2026-10-30
Source partition: 5
Source file: https://download.open.fda.gov/drug/label/drug-label-0005-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-10-30/a900515c00f4d0d29f88cc94ee68daf127f036296f87a6b4a8a3f964cd0433c0/drug-label-0005-of-0014.json.zip
Source manifest SHA-256: b11f1f6b476c7417db937215bf14307ef1a0b69465b42b411ad52f42ae36ead3
Import run: 20261102T182004Z
Imported at: 2026-11-02 18:48:19

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 12 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		Promescent Delay Wipes	openfda.brand_name
generic name		BENZOCAINE	openfda.generic_name
manufacturer name		Absorption	openfda.manufacturer_name
ndc	package	55636-000-01	openfda.package_ndc
ndc	package	55636-000-50	openfda.package_ndc
ndc	product	55636-000	openfda.product_ndc
ndc11	package	55636000050	derived:openfda.package_ndc
ndc11	package	55636000001	derived:openfda.package_ndc
spl id		11d32fcd-926d-7021-e063-6394a90a0499	id
spl set id		f0a5b6be-acc5-473c-9054-b9534e769db1	set_id
unii		U3RSY48JW5	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings Avoid contact with the eyes. Premature ejaculation may be due to a condition requiring medical supervision. If this product, used as directed, does not provide relief, discontinue use and consult a doctor. If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.